|
|
||||||||||
|
J Am Coll Cardiol, 2005; 46:730-732, doi:10.1016/j.jacc.2005.05.043
(Published online 27 July 2005). © 2005 by the American College of Cardiology Foundation |
* Thoraxcenter Room Ba 300, Erasmus MC, Dr. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands (Email: d.poldermans{at}erasmusmc.nl).
The study population consisted of consecutive patients with typical angina who were considered to have a high pre-test probability of CAD (>0.7) referred for DSE. This was considered in the presence of typical angina pectoris in women
50 years of age and in men
30 years of age, according to the published data (3). Patients were excluded if they had a previous myocardial infarction, myocardial revascularization, or significant coronary artery stenosis by angiography. Criteria were fulfilled in 329 patients. The protocol was approved by the Hospital Ethics Committee. Follow-up was successful in 327 patients (99%); 28 (8%) underwent early coronary revascularization (within 60 days after the DSE).
The DSE was performed and interpreted according to a standard protocol as previously reported (1). An abnormal test result was defined as resting wall motion abnormality or ischemia. Follow-up events were overall mortality and hard cardiac events (nonfatal myocardial infarction and cardiac death).
The mean age was 64 ± 10 years. There were 205 (63%) men. Thirty-six (11%) patients had a history of diabetes mellitus, 100 (31%) had hypertension, and 24 (7%) had a history of heart failure. The target heart rate was reached in 262 (80%) patients.
The DSE was normal in 125 (38%) patients. Fixed wall motion abnormalities were detected in 53 (16%) and ischemia was detected in 149 (46%) patients. During a mean follow-up of 6 ± 3.8 years, there were 89 (27%) deaths, of which 52 (16%) were attributed to cardiac causes. Twenty-one (6%) patients experienced nonfatal myocardial infarction. Twenty-five of 125 patients with a normal stress test result (20%) underwent revascularization, whereas 75 of 202 patients with an abnormal test result (37%) underwent revascularization (p = 0.002). Cox proportional hazards regression analysis for the end points of cardiac death, hard cardiac events, and all-cause mortality is presented in Table 1. The presence of myocardial ischemia was an independent predictor for all end points.
|
|
In this study, DSE added independent prognostic information in patients with angina and a high pre-test probability of CAD. Patients with a normal DSE had a lower risk of death and hard cardiac events, whereas in patients with an abnormal DSE, the incidence of all events was substantially higher. The presence of myocardial ischemia was the strongest independent predictor for all end points and was associated with an increased risk of events after adjustment to clinical data.
The prevalence of CAD in patients who present with typical angina is expected to be approximately 90% for men and 70% for women (4). In this study, however, DSE was normal in 38% of the population. The results of our study indicate that patients with a normal DSE have a low event rate during intermediate to long-term follow-up, and therefore these patients, who represent a relatively large proportion of the study population, can be exempted from further (invasive) diagnostic evaluation unless a change in clinical status occurs.
Few studies evaluated the prognostic value of stress echocardiography in patients with a high pre-test probability of CAD. These studies used composite end points that include soft events such as unstable angina and revascularization (5,6), or were not powered enough to show an incremental value of myocardial ischemia alone (7). A recent study by Hachamovitch et al. (8) showed that myocardial perfusion imaging provided incremental prognostic information for predicting cardiac death in 1,270 patients with a high likelihood of CAD who underwent exercise or adenosine stress myocardial perfusion tomography.
Although patients were determined to have a high pre-test probability of CAD in our study, the annual hard cardiac event rate was moderate (4%). This can be explained by the exclusion of patients with previous myocardial infarction, unstable symptoms, and a history of CAD, which resulted in inclusion of a stable population with preserved left ventricular systolic function. Although this study excluded patients with cardiomyopathy, the possible existence of other cardiac conditions that may be associated with cardiac death without ischemia, such as cor pulmonale, may have been confounding. However, the incremental significance of myocardial ischemia was demonstrated despite this potential limitation.
We conclude that in patients with classic angina, determined to have a high pre-test probability of CAD, DSE yields independent prognostic information. A negative DSE is associated with a relatively low event rate for cardiac and all-cause mortality as well as for the combined end point of hard cardiac events. These findings have important clinical implications because these patients can be exempted from invasive studies if they have no change in clinical status. Myocardial ischemia during DSE is independently associated with an increased risk of death after adjustment for clinical data.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. Ansell, J. Hirsh, E. Hylek, A. Jacobson, M. Crowther, and G. Palareti Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 160S - 198S. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |